The ability of pathogenic Escherichia coli to adhere to the intestinal mucosa seems to be an essential step for the mediation of disease.' It enables the organism to overcome host defence mechanisms such as peristalsis and mucus trapping, and therefore allows the bowel to be colonised. Escherichia coli isolated from the faeces of patients with ulcerative colitis differ from those organisms present in control isolates in that they are more likely to produce haemolysin and necrotoxin and more commonly possess the ability to dilate rabbit ileal loops.2 A significant proportion possess a mannose resistant adhesive property34 and this raises the possibility that these organisms may have a role in the pathogenesis of ulcerative colitis.
In ulcerative colitis blood and serum exude from the inflamed mucosa into the lumen of the bowel. The lethal effect of human serum for Gram negative bacteria is well recognised5 and seems to have an important role in host defence. This bactericidal activity is mediated by activation of the complement system, which property is lost when complement is inactivated or depleted. Resistance of bacteria to the bactericidal action of human serum has been shown in many pathogenic strains, particularly invasive strains67 and those causing urinary tract infections.8
The ability to resist the lethal effects of human serum might confer an advantage on faecal E coli in ulcerative colitis and might explain the presence of adhesive and invasive strains3 in the faeces of patients with the disease. Conversely, the possibility of a defect in the bactericidal competence of serum in patients with ulcerative colitis must also be considered.
The aims of this study were to determine whether E coli from patients with ulcerative colitis show increased resistance to the lethal action of human serum and to assess the bactericidal competence of sera from patients with ulcerative colitis on E coli.
The currently accepted methods for determining the resistance of bacteria to sera are time consuming, laborious, and require large amounts of culture media and sera.5 We used a simple screening method, a rapid microtitre technique, which enables many strains to be tested simultaneously using minimal quantities of sera and media.
Methods
Normal human serum was obtained from 10 healthy male and female volunteers who were not receiving antibiotics. The sera were pooled and stored in 2 
Results
The response to incubation with 75% pooled normal serum of the control strains C10 and UB28 1 was confirmed by the method of Taylor et al.9 Figure 1 shows the continued growth of CIO but shows that UB281 is rapidly killed within one hour of incubation with human serum.
Using the microtitre method, visual inspection at three hours showed a noticeable change in colour of the indicator from red to yellow for E coli C1O but no apparent change in colour for UB281.
To determine whether the microtitre 1000- 
Control strain
To confirm the results obtained by the microtitre method 15 isolates (five from !controls, 10 from patients with ulcerative colitis) were studied. Seven were considered to be serum resistant and eight serum sensitive by the microtitre method; this classification was confirmed by the method of Taylor et al.9
To investigate the bactericidal competence of serum from patients with ulcerative colitis UB281 and four E coli isolates from patients with ulcerative colitis known to be sensitive to normal human serum were assayed against sera from 10 patients with ulcerative colitis, using the method of Taylor et al. In each assay a control with heat inactivated sera was included. The mean percentage of the original inoculum remaining viable after one, two, and three hours' incubation with disease serum and pooled normal human serum is shown in fig 3. Although there was more variation in the percentage of the original inoculum viable after incubation with disease sera, in all cases less than 6% of the inoculum remained viable, indicating that all strains were effectively killed by all disease sera in vitro.
Discussion
The ability to study large numbers of bacteria for serum resistance has traditionally been limited by laborious and time consuming methods. Screening methods that have been proposed include plaque assay techniques on agar plates7 but agar itself may have an anticomplement like effect. The detection of radiolabelled lipopolysaccharide released from bacteria susceptible to serum" is limited by the observation that this occurs even when using heat inactivated serum. We adapted the method of Moll, Cabello, and Timms" which relies on the detection of a change in colour of a pH dependent indicator. This method does not rely on viable counting techniques with their inherent disadvantages and has proved to be a simple, rapid and reliable method, useful for screening several strains simultaneously.
Using recognised serum sensitive and resistant strains it was possible to define a range for the change in absorbance that would reliably differentiate between sensitive and resistant E coli. There are limitations with this method in that it detects only organisms that continue to grow in the presence of serum. It will not distinguish between the different patterns of This study shows that the serum in patients with ulcerative colitis is functionally competent and that the potentially hostile environment of the colon with ulcerative colitis does not select for E coli exhibiting serum resistance.
